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Rezumat. Asociaţia parametrilor biochimici al lipidelor din sânge cu t894g gena polimorfi smului endoepitelial 
oxid nitric la pacienţii cu hipotireoză şi colecistită cronică acalculoasă concomitentă
A fost studiată asocierea T894G a polimorfi smului genei eNOS cu lipide şi unii parametri biochimici ai sângelui la 
pacienţii cu hipotireoză şi colecistita cronică acalculoasă concomitentă. Pacienţii cu hipotireoză şi colecistita cronică acal-
culoasă concomitentă la purtătorii T-alelei a fost observată cu 19,2% (p=0,02) mărirea colesterolului lipidelor cu densitate 
joasa în comparaţie cu cele ale pacienţilor cu GG-genotip. Astfel de particularităţi a profi lului lipidic la pacienţii cu T-alela 
a genei eNOS, а contribuit la creşterea indicelui  aterogenic cu 14,4% (p<0,05) în comparaţie cu parametrii corespunzători 
a pacienţilor purtători a GG-genotipului.
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Summary
Association of T894G eNOS gene polymorphism with certain biochemical and lipid blood parameters in patients 
with hypothyroidism and concomitant chronic noncalculous cholecystitis was investigated. Patients with hypothyroidism 
and concomitant chronic noncalculous cholecystitis T-allele carriers were characterized by 19,2% (p = 0,02) higher 
cholesterol of low density lipoprotein blood level compared to the appropriate indicator in patients with GG-genotype. 
Such peculiarities in lipid profi le in patients with T-allele of eNOS gene led to the increased value of atherogenic index 
by 14,4% (p < 0,05) compared with proper parameter in patients GG-genotype carriers.
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Резюме. Ассоциация биохимических и липидных показателей крови с t894g полиморфизмом гена эндо-
телиальной синтазы оксида азота у больных гипотиреозом и сопутствующим хроническим некалькулез-
ным холециститом 
Исследована ассоциация T894G полиморфизма гена eNOS с определенными биохимическими и липидными 
показателями крови у больных гипотиреозом и сопутствующим хроническим некалькулезным холециститом. У 
пациентов с гипотиреозом и сопутствующим хроническим некалькулезным холециститом носителей Т-аллеля 
наблюдали на 19,2% (р = 0,02) более высокий уровень холестерина липопротеинов низкой плотности по срав-
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нению с соответствующим показателем у больных с GG-генотипом. Такие особенности липидного профиля у 
пациентов с Т-аллелем гена eNOS привели к увеличению у них индекса атерогенности на 14,4% (р <0,05) по 
сравнению с надлежащим параметром у пациентов носителей GG-генотипа.
Ключевые слова: гипотиреоз, хронический холецистит, ген эндотелиальной синтеза окиси азота
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Introduction
Gene polymorphism of endothelial nitrogen oxide 
synthase (eNOS) has been the object of scientifi c 
interest for many years, since it plays a principal role 
in the regulation of vascular tone [6]. eNOS gene 
encodes the synthesis of the eNOS enzyme, that is 
responsible for the NO production in the vascular 
walls – an essential vasodilatator, antioxidants 
antymitogen and antiplatelet agent [5]. NO plays a 
key role in vascular relaxation, reducing of migration 
and proliferation of vascular smooth muscle cells, 
inhibition of platelet adhesion of leukocytes to the 
endothelium, inhibiting of low-density lipoprotein 
oxidation [4]. eNOS reduced activity, as a result of 
certain minor allelic variants of proper gene leads to a 
decrease in the NO-synthase expression and defi ciency 
and NO blood concentration. Described changes result 
in endothelial dysfunction manifestation [3], leading 
to the atherogenesis development [8]. In particular, it 
was found out, that minor T-allele carriers of the eNOS 
gene show reduced activity of the eNOS enzyme 
[14] and decreased NO blood level [9]. Numerous 
studies indicate an association of minor T-allele of 
eNOS gene (T894G) with a higher incidence of heart 
stroke and arterial hypertension occurrence [1, 2, 12, 
13]. Nozaki Y et al., in experimental studies on mice 
have shown a signifi cant role of defi ciency eNOS-
derived NO blood concentration in the hepatobiliary 
system diseases development, in particular non-
alchoholic fatty liver disease, due to the impact on 
the redistribution of fat in the liver of mice occurred 
due to the hepatic tissue blood fl ow violation [10]. 
We have not found any data about the peculiarities 
of chronic cholecystitis development depending on 
the eNOS gene (T894G) polymorphism, especially 
in patients with hypothyroidism who are prone to the 
development of this pathology.
The objective of the study was to investigate 
a possible association of T894G eNOS gene 
polymorphism with certain biochemical and lipid 
blood parameters in patients with hypothyroidism 
and concomitant chronic noncalculous cholecystitis.
Material and methods
The study involved 52 patients with hypothy-
roidism and concomitant chronic noncalculous cho-
lecystitis (average age 46,1 ± 14,4 years), which were 
signed in research group. Disease duration since the 
diagnosis of hypothyroidism ranged from 1 to 10 
years, chronic cholecystitis between 1 to 5 years re-
spectively. The control group consisted of 20 practi-
cally healthy individuals correlative by their age and 
gender to the groups examined. Blood samples were 
obtained before the morning food intake from ante-
cubital vein before the appointment of treatment. 5% 
solution of disodium salt of ethylene diamine tetraac-
etate was performed as an anticoagulant. The protocol 
of the study was done in accordance with the revised 
Helsinki Declaration (2008) and was approved by 
the local medical ethics committee. Written informed 
agreements were signed by all of the participants.
The range of indicators of biochemical blood 
analysis included: total bilirubin and its fractions, 
total protein and albumin, urea, creatinine, plasma 
enzyme activity (aspartate aminotransferase 
(AST), alanine aminotransferase (ALT), lactate 
dehydrogenase (LDH), gamma-glutamyl transferase 
(GGT), alkaline phosphatase (AP)). Lipid profi le 
of the blood was studied by measuring the content 
of cholesterol, triacylglycerols, cholesterol of high 
density lipoproteins (HDL), cholesterol of low 
density lipoproteins (LDL), cholesterol of very low 
density lipoproteins (VLDL) in plasma. Atherogenic 
index was calculated on the base of received data. 
Biochemical studies were performed on the blood 
biochemical analyzer “Accent-200” (“Cormay SA”, 
Poland).
Investigation of T894G polymorphism of 
eNOS gene was carried out in the state institution 
“Reference Center for Molecular Diagnostics of 
the Ministry of Public Health of Ukraine” (Kyiv, 
Ukraine). To determine the polymorphic variants of 
eNOS gene (G894T) (rs1799983) modifi ed protocols 
with specifi c oligonucleotide primers (“Metabion”, 
Germany) were used (Table 1) [11] using the method 
Table 1 
Oligonucleotide primers 







of polymerase chain reaction (PCR) and subsequent 
analysis of restriction fragment length polymorphism. 
The amplifi cation products (amplicons) of eNOS 
gene (G894T) were evaluated in gel electrophoresis 
and only if proper DNA fragment of 248 bp was 
investigated subsequent analysis of restriction 
fragment length polymorphism was performed. For 
this purpose, amplicon obtained hydrolytic cleavage 
using restriction enzyme MboI (“Thermo Scientifi c”, 
USA). Amplifi ed fragments were analyzed by 2% 
agarose gel (“Cleaver Scientifi c”, UK), with the 
addition of ethidium bromide, molecular weight 
marker GeneRuler 50 bp DNA Ladder (“Thermo 
Scientifi c”, USA). Obtained results were visualized 
in transilluminator by the computer program Vitran.
To determine the type of data distribution, 
comparing the arithmetic mean and Wilcoxon-
Shapiro test were used. To investigate the statistical 
differences between two independent groups Mann-
Whitney test was used. Hardy-Weinberg equilibrium 
was calculated by a χ-square test. p values < 0,05 
were considered statistically signifi cant.
Results and discussion
Polymorphism (T894G) of eNOS gene was 
studied in 52 patients with hypothyroidism and 
concomitant chronic noncalculous cholecystitis and 
20 healthy volunteers. The distribution of genotypes 
of the eNOS gene polymorphism is shown in table 2.
In the group of healthy individuals it was found: 
1 (5,0%) person with TT-genotype, 10 (50,0%) 
heterozygous carriers and 9 carriers of GG-genotype 
(45,0%). T-allele of eNOS gene among healthy 
individuals was observed in 12 (30,0%) of 40 selected 
alleles, G-allele – in 28 (70,0%), respectively. 
Accordance of genotypes distribution with the Hardy-
Weinberg equilibrium in the control group was tested 
using χ-square test with 1 degree of freedom, without 
Yates correction. As the result of this calculation it 
was found, that genotypes distribution in the control 
group complies with the Hardi-Weinberg equilibrium.
Among patients with hypothyroidism and 
concomitant chronic noncalculous cholecystitis 4 
(7,7%) had TT genotype, 20 (38,5%) – TG-genotype, 
28 (53,8%) – GG-genotype. T-allele of eNOS gene 
was observed in 28 (26,9%) of 104 cases selected 
alleles, G-allele – in 76 (73,1%), respectively. Using 
the χ-square test with 2 degrees of freedom, we 
found no statistically signifi cant differences in the 
distribution of genotypes among observed patients 
and healthy people.
The method of determining the odds ratio (OR) 
established that frequency of T- and G-allele did not 
differ signifi cantly in patients with hypothyroidism 
and concomitant chronic noncalculous cholecystitis 
and a group of healthy individuals OR = 0,86 (95% 
CI 0,39 – 1,92).
The analysis of biochemical blood indicators of 
the patients according to the T894G polymorphism 
of the eNOS gene was provided (Table 3). As the 
number of TT-genotype carriers was limited (n = 4), 
we conducted an analysis of the parameters studied 
for the presence of minor T-allele. As a result of 
this analysis, any statistically signifi cant differences 
between the rates of biochemical blood analysis and 
different allelic polymorphism of the eNOS gene 
(T894G) in the observed patients were found.
The analysis of the possible association between 
options of lipid profi le and allelic polymorphism of the 
eNOS gene (T894G), established signifi cantly higher 
levels of cholesterol of low density lipoproteins in 
the patients T-allele carriers. In this group of patients 
it was in 19,2% (p = 0,02) higher compared to the 
appropriate indicator in patients with GG-genotype 
(Table 4). These fi ndings confi rm data of other 
investigators [4, 7], who postulate that NO plays 
an important role in the metabolism of low density 
lipoproteins. The mechanisms of such association 
require further investigations. 
These changes causes a signifi cant increase in 
atherogenic index in patients with T-allele in which 
Table 2 
Distribution of the eNOS gene polymorphism (T894G) in patients with hypothyroidism and concomitant 
chronic noncalculous cholecystitis and healthy individuals
eNOS gene genotype
Patients with hypothyroidism and 









TT 4 7,7 1 5,0%
TG 20 38,5 10 50,0%
GG 28 53,8 9 45,0%
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it was by 14,4% (p < 0,05) elevated compared with 
corresponding fi gure in patients GG-allele carriers. 
No signifi cant differences in other parameters of lipid 
profi le were found.
Conclusions
1. Patients with hypothyroidism and concomi-
tant chronic noncalculous cholecystitis T-allele car-
riers were characterized by 19,2% (p = 0,02) high-
er cholesterol of low density lipoprotein blood level 
compared to the appropriate indicator in patients with 
GG-genotype.
2. Such peculiarities in lipid profi le in patients 
Table 3 
Biochemical blood parameters in patients with hypothyroidism and concomitant chronic noncalculous 





Patients with hypothyroidism and 
concomitant chronic noncalculous 
cholecystitis, n = 52
GG-genotype 
carriers, n = 28
T-allele carriers, 
n = 24
Glucose, mmol/l (N= 3,9-6,0 mmol/L) 4,7 ± 0,09 5,1 ± 0,28 5,2 ± 0,31
Total bilirubin, mkmol/L (N=5,0-20,5) 12,0 ± 1,46 10,9 ± 1,19 10,4 ± 0,68
Direct bilirubin, mkmol/L (N=0,5-5,0) 3,6 ± 0,60 2,6 ± 0,28 2,4 ± 0,25
Albumin, g/L (N=35-50) 44,3 ± 0,57 45,3 ± 0,65 44,1 ± 0,45
Total protein, g/L (N=65-85) 68,5 ± 0,88 71,4 ± 1,18 69,8 ± 0,79
Urea, mmol/L (N=2,4-8,3) 4,4 ± 0,40 4,6 ± 0,32 4,6 ± 0,30
Creatinine, mkmol/L (N=40-110) 80,5 ± 2,72 80,8 ± 2,13 81,1 ± 2,65
Aspartate aminotransferase, units of action/L 





Alanine aminotransferase, units of action/l 
(N<32) 14,7 ± 2,01
23,0 ± 2,90
p1 = 0,01 
23,2 ± 3,06
p1 = 0,01
Lactate dehydrogenase, units of action/L 





Alkaline phosphatase, units of action/L (N=42-





Gamma-glutamyl transferase, units of action/L 





Comment: p1 – signifi cance of differences compared with fi gures in the group of healthy people.
Table 4 
Lipid profi le in patients with hypothyroidism and concomitant chronic noncalculous cholecystitis 





Patients with hypothyroidism and concomitant chronic 





Cholesterol, mmol/l 4,32 ± 0,15 5,38 ± 0,24p1 < 0,0001
5,85 ± 0,30
p1 < 0,0001
Triacylglycerols, mmol/l 0,74 ± 0,05 1,63 ± 0,20p1 < 0,0001
1,54 ± 0,20
p1 < 0,0001
Cholesterol HDL, mmol/l 1,44 ± 0,06 1,49 ± 0,05 1,50 ± 0,05




Cholesterol VLDL, mmol/l 0,36 ± 0,03 0,77 ± 0,09p1 < 0,0001
0,78 ± 0,10
p1 < 0,0001




Comment: p1 – signifi cance of differences compared with the fi gures in the group of healthy people; p2 – signifi cance of differences 
compared with rates in patients with the GG-genotype.
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with T-allele of eNOS gene lead to the increased val-
ue of atherogenic index by 14,4% (p < 0,05) com-
pared with proper parameter in patients GG-genotype 
carriers.
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